What is Advanced Enzyme Technologies Ltd. Quarterly Revenue?

Advanced Enzyme Technologies Ltd. Quarterly Revenue Advanced Enzyme Jun-2026 Quarterly Revenue is Rs 118 Cr which is growth of -34.0% YoY.

What is Advanced Enzyme Technologies Ltd. Quarterly Net Profit?

Advanced Enzyme Technologies Ltd. Quarterly Net Profit Advanced Enzyme Jun-2026 Quarterly Net Profit is Rs 22 Cr which is growth of -69.8% YoY.

What is Advanced Enzyme Technologies Ltd. Annual Revenue?

Advanced Enzyme Technologies Ltd. Annual Revenue Advanced Enzyme Mar-2026 Annual Revenue is Rs 516 Cr which is growth of 25.0% YoY.

What is Advanced Enzyme Technologies Ltd. Annual Net Profit?

Advanced Enzyme Technologies Ltd. Annual Net Profit Advanced Enzyme Mar-2026 Annual Net Profit is Rs 132 Cr which is growth of 28.7% YoY.

What is Advanced Enzyme Technologies Ltd. Total Shareholders Fund?

Advanced Enzyme Technologies Ltd. Total Shareholders Fund Advanced Enzyme Mar-2026 Total Shareholders Fund is Rs 710 Cr which is growth of 12.8% YoY.

What is Advanced Enzyme Technologies Ltd. Total Assets?

Advanced Enzyme Technologies Ltd. Total Assets Advanced Enzyme Mar-2026 Total Assets is Rs 804 Cr which is growth of 16.7% YoY.

What is Advanced Enzyme Technologies Ltd. Book Value Per Share?

Advanced Enzyme Technologies Ltd. Book Value Per Share Advanced Enzyme Mar-2026 Book Value Per Share is 63 Rs which is growth of 12.7% YoY.

What is Advanced Enzyme Technologies Ltd. ROE?

Advanced Enzyme Technologies Ltd. ROE Advanced Enzyme Mar-2026 ROE is 19% which is growth of 2.3% YoY.

What is Advanced Enzyme Technologies Ltd. Cash From Operating Activity?

Advanced Enzyme Technologies Ltd. Cash From Operating Activity Advanced Enzyme Mar-2026 Cash From Operating Activity is Rs 89 Cr which is growth of 39.8% YoY.

What is Advanced Enzyme Technologies Ltd. Net Cash Flow?

Advanced Enzyme Technologies Ltd. Net Cash Flow Advanced Enzyme Mar-2026 Net Cash Flow is Rs -4 Cr which is growth of -190.3% YoY.

Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES | BSE: 540025

Mid-range Performer

Download real time

Clinical Trials Patent Approvals

-0.55(-0.19%)

32.79% Fall from 52W High

128.0K

NSE+BSE Volume

NSE 30 Sep, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Advanced Enzyme quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Advanced Enzyme share price target, revenues, EPS, net income and more

Advanced Enzyme quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Advanced Enzyme Jun-2026 Quarterly Revenue is Rs 118 Cr which is growth of -34.0% YoY.
NEGATIVE
Quarterly Net Profit Advanced Enzyme Jun-2026 Quarterly Net Profit is Rs 22 Cr which is growth of -69.8% YoY.

Advanced Enzyme Technologies Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	118.1	121.6	96.9	118.8	178.9	91.7	102.3	79	139.8	95.6	94.7	97.4	136.6
SR_Q Operating Rev.	115.9	116.4	95.6	115.8	125	87.2	100.9	77.4	86	92.4	91.1	96.6	85.4
OI_Q Other Income	2.3	5.2	1.3	3.1	53.9	4.5	1.4	1.7	53.9	3.2	3.6	0.8	51.3
OEXPNS_Q Operating Exp.	85.4	89.6	72.1	86.2	94.5	73	78.8	63.9	65	63.2	66.6	70	60.6
OEXPNS_Q Operating Exp.	85.4	89.6	72.1	86.2	94.5	73	78.8	63.9	65	63.2	66.6	70	60.6
OP_Q Operating Profit	30.4	26.9	23.5	29.6	30.5	14.2	22.1	13.5	20.9	29.2	24.6	26.6	24.8
OPMPCT_Q Operating Profit Margin %	26.25%	23.07%	24.55%	25.57%	24.42%	16.25%	21.87%	17.48%	24.34%	31.65%	26.93%	27.56%	29.03%
DEP_Q Depr.	2.9	3.1	3	3	2.9	3.1	2.9	2.8	2.6	3.1	2.7	2.6	2.5
INT_Q Interest	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0	0
PBT_Q Profit Before Tax	29.7	28.8	17.8	29.6	81.4	15.5	20.5	12.3	72.2	10.4	25.4	24.8	73.5
TAX_Q Tax	7.4	6.6	4.6	7.3	7.4	4.5	5.4	3.2	5.1	7.3	6.2	6.4	6
NP_Q Net Profit	22.4	22.3	13.3	22.3	74	11.1	15.2	9.1	67.1	3.1	19.1	18.4	67.5
EPS_adj_Q EPS Adj. latest	2	2	1.2	2	6.6	1	1.4	0.8	6	0.3	1.7	1.6	6
NP_TTM Net profit TTM	80.2	131.8	120.6	122.5	109.3	102.4	94.5	98.4	107.7	108.1	122.5	120	115.2
EPS_TTM Basic EPS TTM	7.2	11.8	10.8	11	9.8	9.2	8.5	8.8	9.6	9.7	11	10.7	10.3
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Advanced Enzyme competitor comparison and performance snapshot within industry

Advanced Enzyme annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Advanced Enzyme Mar-2026 Annual Revenue is Rs 516 Cr which is growth of 25.0% YoY.
POSITIVE
Annual Net Profit Advanced Enzyme Mar-2026 Annual Net Profit is Rs 132 Cr which is growth of 28.7% YoY.

Advanced Enzyme Technologies Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	17.1%	12.2%	455.4	516.2	412.9	424.3	321.3	281.9	290.3	256.4	227.7	217.1	179.1	139.9
TotalOperatingRevenues_A Operating Rev. Ann.	13.3%	9.8%	443.6	452.8	351.4	365.5	311.5	272.8	283.5	247.4	222.1	212.1	172.6	139.1
OI_A Other Income Ann.	86.3%	56.3%	11.8	63.4	61.5	58.8	9.8	9.1	6.8	9	5.6	5.1	6.4	0.8
OEXPNS_A Operating Exp. Ann.	13.1%	13.4%	333.3	342.3	280.7	260.3	236.6	200.2	182.9	170.6	169.7	162.4	124.4	102.2
OEXPNS_A Operating Exp. Ann.	13.1%	13.4%	333.3	342.3	280.7	260.3	236.6	200.2	182.9	170.6	169.7	162.4	124.4	102.2
OP_A Operating Profit Ann.	13.8%	1.9%	110.3	110.4	70.7	105.2	74.9	72.7	100.6	76.8	52.4	49.7	48.3	37
OPMPCT_A OPM Ann. %	-2.8%	-9.2%		21.40%	17.12%	24.79%	23.31%	25.77%	34.66%	29.95%	23.01%	22.87%	26.97%	26.43%
TotalExpenses_A Total Exp. Ann. ⌄	12.8%	13.1%		354.6	292.4	271.3	247.1	209.8	191.9	180.5	180.5	173.3	135.4	113.9
OtherExpenses_A Other Exp. Ann.	8.8%	12.2%	97.1	93	82.4	78.6	72.3	61.6	52.3	49.2	48.8	44.4	34.9	14.1
EmployeeBenefitExpenses_A Employee Exp. Ann.	16%	13.6%	66.2	64.7	56	50	41.4	39.3	34.2	32.6	35.1	32.5	27.3	24.3
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	27.1%	10.1%		173.8	132.2	164	84.7	81.7	107.4	85.8	58	54.7	54.7	37.8
EBIDTPCT_A EBITDA Ann. margin %	8.5%	-1.9%		33.68%	32.01%	38.65%	26.36%	28.99%	37.01%	33.46%	25.47%	25.20%	30.55%	27.00%
INT_A Interest Ann.	26%	14.9%	0.2	0.2	0.2	0.2	0.1	0.1	0.1	1.1	2.2	3.1	2.7	4.4
DEP_A Depr.	5.5%	6.3%	12.1	12.1	11.4	10.9	10.3	9.6	8.9	8.8	8.6	7.8	8.3	7.4
PBT_A PBT Ann.	28.5%	9.9%	106	157.7	120.5	134	74.3	72.1	98.4	75.9	47.2	43.8	43.7	26
TAX_A Tax Ann.	11.3%	-1.1%	25.8	25.9	18.1	25.9	18.8	17.6	27.4	17.9	12	8	9.1	4.8
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	33.4%	13.2%		131.8	102.4	108.1	55.5	54.5	71	58	35.2	35.9	34.6	21.3
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	33.4%	13.2%	80.2	131.8	102.4	108.1	55.5	54.5	71	58	35.2	35.9	34.6	21.3
NETPCT_A NPM Ann. %	17.8%	3%		29.11%	29.14%	29.58%	17.82%	19.98%	25.05%	23.42%	15.86%	16.92%	20.02%	15.27%
EPS_adj_A EPS Adj. latest Ann.	33.1%	13.4%		11.8	9.2	9.7	5	4.9	6.3	5.2	3.2	3.2	3.1	1.9
result_notes Result Notes				Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

25%

2Y CAGR

10.3%

3Y CAGR

17.1%

5Y CAGR

12.2%

7Y CAGR

12.4%

10Y CAGR

13.9%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

28.7%

2Y CAGR

10.4%

3Y CAGR

33.4%

5Y CAGR

13.2%

7Y CAGR

20.8%

10Y CAGR

20%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

21.9%

2Y CAGR

14.7%

3Y CAGR

13.1%

5Y CAGR

13.4%

7Y CAGR

10.5%

10Y CAGR

12.8%

Operating Expenses Annual Cr growth is higher than historical averages.

Advanced Enzyme balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Advanced Enzyme Mar-2026 Total Shareholders Fund is Rs 710 Cr which is growth of 12.8% YoY.
POSITIVE
Total Assets Advanced Enzyme Mar-2026 Total Assets is Rs 804 Cr which is growth of 16.7% YoY.

Advanced Enzyme Technologies Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	10.5%	10.3%	709.6	629.3	580.5	525.3	480.4	435.5	370.5	319.5	288.9	255.2	174.8
EQCAP_A Equity Share Capital Ann.	0%	0%	22.4	22.4	22.4	22.4	22.4	22.4	22.3	22.3	22.3	22.3	21.8
TotalShareCapital_A Total Share Capital Ann.	0%	0%	22.4	22.4	22.4	22.4	22.4	22.4	22.3	22.3	22.3	22.3	21.8
ReservesAndSurplus_A Reserves Plus Surplus Ann.	11%	10.9%	687.2	607	558.1	503	457.4	410.5	344.5	293.6	266.6	232.9	153.1
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	11%	10.9%	687.2	607	558.1	503	457.4	410.5	344.5	293.6	266.6	232.9	153.1
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	6%	4.8%	16.2	14.6	12.5	13.6	13	12.8	11.1	6.1	10	15.1	31.5
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-2.6%	-1.2%	10.9	11.8	10.7	11.8	11.2	11.6	9	3.9	1.5	2.3	15.8
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-10.6%	-	1	2	1.1	1.4	1		0.2
CL_A Total Current Liabilities Ann. ⌄	28.2%	13.7%	77.8	44.7	40	36.9	36.3	41	41.1	50.4	74.1	47.2	55.2
TradePayables_A Trade Payables Ann.	41.4%	17.9%	51.2	22.7	21.7	18.1	20.3	22.5	13.7	15.6	21.2	8.5	9.8
OtherCurrentLiabilities_A Other Current Liabilities Ann.	10.9%	7%	22.9	18.5	15.8	16.8	13.8	16.3	17.8	16.6	18.8	16	13.4
ShortTermProvisions_A ST Provisions Ann.	23.9%	12.6%	3.8	3.5	2.5	2	2.1	2.1	1.7	1.7	1.8	1.6	2.5
TL_A Total Capital Plus Liabilities Ann.	11.8%	10.4%	803.6	688.6	632.9	575.8	529.6	489.3	422.7	375.9	373	317.5	261.5
FixedAssets_A Fixed Assets Ann. ⌄	9%	7.6%	199.3	177.3	164	153.9	140.7	138.4	136.9	104.4	108.2	106.4	109.3
TangibleAssets_A Tangible Assets Ann.	0.7%	2.3%	145.5	150.9	141.8	142.4	131.5	129.8	125.2	95	97.6	98.2	101.2
IntangibleAssets_A Intangible Assets Ann.	133.6%	33.6%	5.1	5.6	0.3	0.4	0.5	1.2	1.8	2.3	0.3	0.1	0.1
CapitalWorkInProgress_A Capital Work In Progress Ann.	105.6%	89.4%	48.7	20.7	16.4	5.6	3.2	2	4.6	1.3	2.4	1.5	1.8
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	8%	8.2%	487.7	456.4	384.6	386.7	352.9	329	292.5	268.9	264	217.3	180.3
NonCurrentInvestments_A Non Current Investments Ann.	11.1%	10.9%	254.3	253.7	205.5	185.5	172.7	151.6	119.8	120.5	120	103.4	53.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-85.6%	-67.8%	0.1	0.1	0	33.3	24.4	28.9	26.5	35.5	29.4	1.4	17.8
OtherNonCurrentAssets_A Other Non Current Assets Ann.	34.3%	27.2%	33.9	25.4	15.1	14	15.2	10.2	9.2	8.5	6.4	6.1	0.1
CA_A Total Current Assets Ann. ⌄	18.7%	14.5%	316	232.2	248.3	189.1	176.7	160.3	130.2	107	109	100.3	81.2
CurrentInvestments_A Current Investments Ann.	78.6%	22.6%	91.1	36.7	50.8	16	16.7	32.9	1
TradeReceivables_A Trade Receivables Ann.	12.2%	11.5%	94.3	78.2	75.2	66.7	49.1	54.7	51.9	38.2	38.6	31	22.8
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-54.7%	3.9%	2.3	5.8	18.6	24.7	18	1.9	3	0.5	0.5	0.6	1.5
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-	0.2	0	0	0	5.8	0	0	0	2.1	2.1	2.8
OtherCurrentAssets_A Other Current Assets Ann.	33.3%	9.7%	11.6	10.1	6.9	4.9	7.1	7.3	14.6	9.7	13	15.6	6.7
TA_A Total Assets Ann.	11.8%	10.4%	803.6	688.6	632.9	575.8	529.6	489.3	422.7	375.9	373	317.5	261.5
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	48.9%	31.3%	45.2	20	17.7	13.7	8.6	11.6	16.1	30.9	30.5	26	19.8
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	15.6	15.6	15.6	15.6	15.6	15.6	15.6	15.6	15.6	15.6	15.6
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	0%	0%	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	120	103.4	53.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-							1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

16.7%

2Y CAGR

12.7%

3Y CAGR

11.8%

5Y CAGR

10.4%

7Y CAGR

11.5%

10Y CAGR

11.9%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

74%

2Y CAGR

39.5%

3Y CAGR

28.2%

5Y CAGR

13.7%

7Y CAGR

6.4%

10Y CAGR

3.5%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

12.8%

2Y CAGR

10.6%

3Y CAGR

10.5%

5Y CAGR

10.3%

7Y CAGR

12.1%

10Y CAGR

15%

Total ShareHolders Funds Annual growth is higher than historical averages.

Advanced Enzyme ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Advanced Enzyme Mar-2026 Book Value Per Share is 63 Rs which is growth of 12.7% YoY.
POSITIVE
ROE Advanced Enzyme Mar-2026 ROE is 19% which is growth of 2.3% YoY.

Advanced Enzyme Technologies Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	10.5%	10.2%	63.4	56.3	51.9	47	43	39	33.2	28.6	25.9	114.3	80.3
ROA_A RoA Ann. %	19.4%	2.5%	16.40%	14.87%	17.08%	9.64%	10.29%	14.51%	13.71%	9.37%	9.62%	10.88%	8.12%
ROE_A ROE Ann. %	20.7%	2.6%	18.57%	16.27%	18.62%	10.56%	11.34%	16.30%	15.64%	11.02%	12.42%	13.54%	12.15%
ROCE_A ROCE Ann. %	17.3%	0.3%	22.28%	18.75%	25.82%	13.80%	14.62%	21.97%	20.16%	15.18%	15.68%	17.15%	14.73%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	12.2%	0.3%	38.39%	37.61%	44.87%	27.18%	29.95%	37.90%	34.67%	26.11%	25.80%	31.68%	27.15%
PBITMargin_A EBIT Ann. Margin %	14.4%	0.6%	35.72%	34.36%	41.89%	23.88%	26.45%	34.75%	31.11%	22.25%	22.11%	26.86%	21.85%
PBTMargin_A PBT Ann. Margin %	13.5%	0.1%	34.82%	34.29%	36.66%	23.84%	26.41%	34.72%	30.66%	21.25%	20.67%	25.28%	18.70%
NETPCT_A NPM Ann. %	17.8%	3%	29.11%	29.14%	29.58%	17.82%	19.98%	25.05%	23.42%	15.86%	16.92%	20.02%	15.27%
ASETTO_A Asset Turnover Ann. %	0%	0%	0.6	0.5	0.6	0.6	0.5	0.6	0.6	0.6	0.6	0.6	0.6
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-7%	1%	4.1	5.2	6.2	5.1	4.9	3.9	3.2	2.1	1.5	2.1	1.5
QuickRatio_A Quick Ratio Ann.	-4.7%	1.6%	2.6	2.9	3.8	3	2.7	2.4	1.7	1	0.7	1	0.6
DividendPayoutNP_A Dividend Payout to NP Ann.	26%	32%	0.4	0.6	0.5	0.2	0.2	0.1	0.1	0.2	0.1		-
EarningRetention_A Earning Retention Ann. %	-11.2%	-9.2%	55.87%	44.32%	48.29%	79.87%	81.55%	90.57%	88.44%	84.16%	87.56%		89.76%
CashEarningRetention_A Cash Earning Retention Ann. %	-10.5%	-8.2%	59.57%	49.90%	53.03%	83.01%	84.30%	91.62%	89.97%	87.26%	89.79%		92.40%
CashEarningRetention_A Cash Earning Retention Ann. %	-10.5%	-8.2%	59.57%	49.90%	53.03%	83.01%	84.30%	91.62%	89.97%	87.26%	89.79%		92.40%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	3.6%	-5.8%	2,856.2	3,114.5	3,867.4	2,565.7	3,136.1	3,851.5	1,604.3	2,059.8	2,418.1	4,631.9
EVPerNetSales_A EV Per Net Sales Ann.	-8.4%	-14.3%	6.3	8.9	10.6	8.2	11.5	13.6	6.5	9.3	11.4	26.8	-
PBV_A Price To Book Value Adjusted	-9.5%	-9.3%	4.44	5.23	5.42	5.99	6.55	7.23	8.49	9.84	10.88	2.46	3.51
EVPerEBITDA_A EV Per EBITDA Ann.	-18.5%	-14.5%	16.4	23.6	23.6	30.3	38.4	35.9	18.7	35.5	44.2	84.7	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-8.8%	-14.3%	6.3	8.9	10.6	8.3	11.6	13.6	6.5	9.2	11.2	26.6	-
RetentionRatios_A Retention Ratio Ann. %	-11.2%	-9.2%	55.86%	44.31%	48.28%	79.86%	81.54%	90.56%	88.43%	84.15%	87.55%		89.75%
EYield_A Earnings Yield Ann.	-	-	0.1	0	0	0	0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.									0	0.1	0.1	0.1	0.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

14.1%

2Y CAGR

-0.1%

3Y CAGR

20.7%

5Y CAGR

2.6%

7Y CAGR

7.7%

10Y CAGR

4.3%

ROE Annual % is stable compared to historical averages.

RoA Ann. %

1Y CHG

10.3%

2Y CAGR

-2%

3Y CAGR

19.4%

5Y CAGR

2.5%

7Y CAGR

8.3%

10Y CAGR

7.3%

RoA Annual % is stable compared to historical averages.

Current Ratio Ann.

1Y CHG

-21.2%

2Y CAGR

-18.7%

3Y CAGR

-7%

5Y CAGR

7Y CAGR

10%

10Y CAGR

10.6%

Current Ratio Annual is falling faster than historical averages.

Advanced Enzyme cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Advanced Enzyme Mar-2026 Cash From Operating Activity is Rs 89 Cr which is growth of 39.8% YoY.
NEGATIVE
Net Cash Flow Advanced Enzyme Mar-2026 Net Cash Flow is Rs -4 Cr which is growth of -190.3% YoY.

Advanced Enzyme Technologies Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	20.8%	1%	88.7	63.5	55.8	50.3	37.1	84.2	46	35.4	22.6	21.1	31.5
PBT_A PBT Ann.	28.5%	9.9%	157.7	120.5	134	74.3	72.1	98.4	75.9	47.2	43.8	43.7	26
INT_A Interest Ann.	26%	14.9%	0.2	0.2	0.2	0.1	0.1	0.1	1.1	2.2	3.1	2.7	4.4
TAX_A Tax Ann.	11.3%	-1.1%	25.9	18.1	25.9	18.8	17.6	27.4	17.9	12	8	9.1	4.8
CFI_A Cash from Investing Act. Ann.	-	-	-34.2	-1.7	-6.9	-42.4	-14.2	-69.9	-25.7	-1.9	-22.1	-54.8	-35.7
CFA_A Cash from Financing Act. Ann.	-	-	-58.3	-57.6	-56.9	-12	-10.9	-15.5	-17.8	-33.5	-0.6	33.5	4.9
NCF_A Net Cash Flow Ann. ⌄	-	-	-3.7	4.1	-8	-4.1	12	-1.2	2.5		-0.1	-0.2	0.7
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-25.4%	15.7%	5.6	1.5	9.5	13.5	1.5	2.7	0.2	0.2	0.3	0.5	0.9
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-41.5%	4.8%	1.9	5.6	1.5	9.5	13.5	1.5	2.7	0.2	0.2	0.3	1.5

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

39.7%

2Y CAGR

26.1%

3Y CAGR

20.8%

5Y CAGR

7Y CAGR

14%

10Y CAGR

10.9%

Cash from Operating Activity Annual growth is higher than historical averages.

Advanced Enzyme investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

32.79% Fall from 52W High

Advanced Enzyme quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Advanced Enzyme - Forecaster

Forecaster Analyst Estimates for Advanced Enzyme share price target, revenues, EPS, net income and more